FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2903835529> ?p ?o ?g. }

• W2903835529 endingPage "e0206074" @default.
• W2903835529 startingPage "e0206074" @default.
• W2903835529 abstract "The Tathmini GBV study was a cluster randomized trial to assess the impact of a comprehensive health facility- and community-based program delivered through the HIV/AIDS program platform on reduction in gender-based violence and improved care for survivors. Twelve health facilities and surrounding communities in the Mbeya Region of Tanzania were randomly assigned to intervention or control arms. Population-level effects were measured through two cross-sectional household surveys of women ages 15–49, at baseline (n = 1,299) and at 28 months following program scale-out (n = 1,250). Delivery of gender-based violence services was assessed through routine recording in health facility registers. Generalized linear mixed effects models and analysis of variance were used to test intervention effects on population and facility outcomes, respectively. At baseline, 52 percent of women reported experience of recent intimate partner violence. The odds of reporting experience of this violence decreased by 29 percent from baseline to follow-up in the absence of the intervention (time effect OR = 0.71, 95% CI: 0.57–0.89). While the intervention contributed an additional 15 percent reduction, the effect was not statistically significant. The program, however, was found to contribute to positive, community-wide changes including less tolerance for certain forms of violence, more gender equitable norms, better knowledge about gender-based violence, and increased community actions to address violence. The program also led to increased utilization of gender-based violence services at health facilities. Nearly three times as many client visits for gender-based violence were recorded at intervention (N = 1,427) compared to control (N = 489) facilities over a 16-month period. These visits were more likely to include provision of an HIV test (55.3% vs. 19.6%, p = .002). The study demonstrated the feasibility and impact of integrating gender-based violence and HIV programming to combat both of these major public health problems. Further opportunities to scale out GBV prevention and response strategies within HIV/AIDS service delivery platforms should be pursued. Trial Registration: Pan African Clinical Trials Registry No. PACTR201802003124149." @default.
• W2903835529 created "2018-12-22" @default.
• W2903835529 creator A5006026658 @default.
• W2903835529 creator A5007672918 @default.
• W2903835529 creator A5018697440 @default.
• W2903835529 creator A5024448762 @default.
• W2903835529 creator A5029524936 @default.
• W2903835529 creator A5029771361 @default.
• W2903835529 creator A5036022502 @default.
• W2903835529 creator A5039376272 @default.
• W2903835529 creator A5039602009 @default.
• W2903835529 creator A5039663600 @default.
• W2903835529 creator A5043507894 @default.
• W2903835529 creator A5062224647 @default.
• W2903835529 creator A5065480414 @default.
• W2903835529 creator A5066606428 @default.
• W2903835529 creator A5082321375 @default.
• W2903835529 date "2018-12-06" @default.
• W2903835529 modified "2023-10-17" @default.
• W2903835529 title "Cluster randomized trial of comprehensive gender-based violence programming delivered through the HIV/AIDS program platform in Mbeya Region, Tanzania: Tathmini GBV study" @default.
• W2903835529 cites W1445689570 @default.
• W2903835529 cites W1601988052 @default.
• W2903835529 cites W1919681536 @default.
• W2903835529 cites W1987276314 @default.
• W2903835529 cites W1993503567 @default.
• W2903835529 cites W2009355390 @default.
• W2903835529 cites W2020850101 @default.
• W2903835529 cites W2038426830 @default.
• W2903835529 cites W2048435729 @default.
• W2903835529 cites W2056705769 @default.
• W2903835529 cites W2072701834 @default.
• W2903835529 cites W2091214577 @default.
• W2903835529 cites W2096210540 @default.
• W2903835529 cites W2098567431 @default.
• W2903835529 cites W2103027789 @default.
• W2903835529 cites W2104348615 @default.
• W2903835529 cites W2110676524 @default.
• W2903835529 cites W2110959673 @default.
• W2903835529 cites W2120241461 @default.
• W2903835529 cites W2120986885 @default.
• W2903835529 cites W2126519784 @default.
• W2903835529 cites W2126544305 @default.
• W2903835529 cites W2127502584 @default.
• W2903835529 cites W2127952723 @default.
• W2903835529 cites W2129224144 @default.
• W2903835529 cites W2129624909 @default.
• W2903835529 cites W2132488181 @default.
• W2903835529 cites W2135823501 @default.
• W2903835529 cites W2138974644 @default.
• W2903835529 cites W2146316233 @default.
• W2903835529 cites W2153481889 @default.
• W2903835529 cites W2255709864 @default.
• W2903835529 cites W2421093551 @default.
• W2903835529 cites W2531486524 @default.
• W2903835529 cites W2562423389 @default.
• W2903835529 cites W2621639744 @default.
• W2903835529 cites W2948982451 @default.
• W2903835529 doi "https://doi.org/10.1371/journal.pone.0206074" @default.
• W2903835529 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6283609" @default.
• W2903835529 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30521530" @default.
• W2903835529 hasPublicationYear "2018" @default.
• W2903835529 type Work @default.
• W2903835529 sameAs 2903835529 @default.
• W2903835529 citedByCount "14" @default.
• W2903835529 countsByYear W29038355292019 @default.
• W2903835529 countsByYear W29038355292020 @default.
• W2903835529 countsByYear W29038355292021 @default.
• W2903835529 countsByYear W29038355292022 @default.
• W2903835529 countsByYear W29038355292023 @default.
• W2903835529 crossrefType "journal-article" @default.
• W2903835529 hasAuthorship W2903835529A5006026658 @default.
• W2903835529 hasAuthorship W2903835529A5007672918 @default.
• W2903835529 hasAuthorship W2903835529A5018697440 @default.
• W2903835529 hasAuthorship W2903835529A5024448762 @default.
• W2903835529 hasAuthorship W2903835529A5029524936 @default.
• W2903835529 hasAuthorship W2903835529A5029771361 @default.
• W2903835529 hasAuthorship W2903835529A5036022502 @default.
• W2903835529 hasAuthorship W2903835529A5039376272 @default.
• W2903835529 hasAuthorship W2903835529A5039602009 @default.
• W2903835529 hasAuthorship W2903835529A5039663600 @default.
• W2903835529 hasAuthorship W2903835529A5043507894 @default.
• W2903835529 hasAuthorship W2903835529A5062224647 @default.
• W2903835529 hasAuthorship W2903835529A5065480414 @default.
• W2903835529 hasAuthorship W2903835529A5066606428 @default.
• W2903835529 hasAuthorship W2903835529A5082321375 @default.
• W2903835529 hasBestOaLocation W29038355291 @default.
• W2903835529 hasConcept C141071460 @default.
• W2903835529 hasConcept C144024400 @default.
• W2903835529 hasConcept C149923435 @default.
• W2903835529 hasConcept C159110408 @default.
• W2903835529 hasConcept C164866538 @default.
• W2903835529 hasConcept C168563851 @default.
• W2903835529 hasConcept C176400912 @default.
• W2903835529 hasConcept C199360897 @default.
• W2903835529 hasConcept C27415008 @default.
• W2903835529 hasConcept C2779357621 @default.
• W2903835529 hasConcept C2780665704 @default.
• W2903835529 hasConcept C2908647359 @default.

• next